Adverum Biotechnologies, Inc.
ADVM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $61 | $75 | $68 | $34 |
| Short-Term Investments | $65 | $22 | $117 | $271 |
| Receivables | $0 | $0 | $0 | $6 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $6 | $5 | $6 |
| Total Curr. Assets | $131 | $103 | $191 | $317 |
| Property Plant & Equip (Net) | $45 | $50 | $114 | $119 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $3 | $3 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $3 | $1 | $0 |
| Total NC Assets | $49 | $53 | $118 | $123 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $180 | $156 | $308 | $440 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $2 | $1 |
| Short-Term Debt | $6 | $5 | $13 | $2 |
| Tax Payable | $0 | $0 | $0 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $15 | $12 | $17 | $17 |
| Total Curr. Liab. | $23 | $20 | $32 | $21 |
| LT Debt | $86 | $69 | $94 | $101 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $1 | $1 |
| Total NC Liab. | $86 | $69 | $95 | $102 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $92 | $74 | $107 | $101 |
| Total Liabilities | $109 | $89 | $127 | $124 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,067 | -$936 | -$803 | -$648 |
| AOCI | -$0 | -$0 | -$2 | -$1 |
| Other Equity | $1,138 | $1,004 | $986 | $965 |
| Total Equity | $71 | $67 | $182 | $316 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $180 | $156 | $308 | $440 |
| Net Debt | $31 | -$1 | $38 | $69 |